Table 3.
Comparison of regional WMV between the control group and COVID-19 group
Region (cm3) | Left |
Right |
||||||
---|---|---|---|---|---|---|---|---|
Control (n=39) | COVID19 (n=60) | F | p value | Control (n=39) | COVID19 (n=60) | F | P value | |
MCP (bilateral) | 10.97 | 11.51 | 111 | 0.144 | 10.97 | 11.51 | 111 | 0.144 |
PCT (bilateral) | 1.14 | 1.17 | 68 | 0.510 | 1.14 | 1.17 | 68 | 0.510 |
CC (bilateral) | 23.27 | 23.17 | 7 | 0.947 | 23.27 | 23.17 | 7 | 0.947 |
Fornix (bilateral) | 0.30 | 0.30 | 4 | 0.956 | 0.30 | 0.30 | 4 | 0.956 |
CST | 1.05 | 1.08 | 98 | 0.456 | 1.05 | 1.07 | 42 | 0.599 |
ML | 0.52 | 0.53 | 65 | 0.510 | 0.51 | 0.52 | 56 | 0.510 |
ICP | 0.69 | 0.72 | 100 | 0.456 | 0.70 | 0.72 | 86 | 0.456 |
SCP | 0.54 | 0.55 | 80 | 0.507 | 0.53 | 0.54 | 52 | 0.554 |
CP | 1.61 | 1.65 | 97 | 0.456 | 1.60 | 1.61 | 26 | 0.779 |
IC | 6.09 | 6.23 | 81 | 0.507 | 6.31 | 6.36 | 18 | 0.812 |
CR | 12.97 | 13.25 | 71 | 0.510 | 13.02 | 13.30 | 57 | 0.510 |
PTR | 2.87 | 2.87 | 3 | 0.958 | 3.04 | 3.02 | 8 | 0.924 |
SS | 1.61 | 1.65 | 83 | 0.456 | 1.69 | 1.72 | 53 | 0.554 |
EC | 3.03 | 3.12 | 58 | 0.510 | 2.96 | 3.03 | 47 | 0.554 |
Cingulate | 1.91 | 1.91 | 5 | 0.947 | 1.60 | 1.59 | 5 | 0.947 |
Hippocampus | 0.73 | 0.72 | 24 | 0.799 | 0.81 | 0.80 | 30 | 0.701 |
SLF | 4.99 | 4.98 | 2 | 0.987 | 5.08 | 5.10 | 6 | 0.947 |
SFF | 0.30 | 0.31 | 85 | 0.456 | 0.30 | 0.30 | 45 | 0.568 |
UF | 0.21 | 0.20 | 46 | 0.557 | 0.23 | 0.22 | 15 | 0.820 |
Tapetum | 0.14 | 0.15 | 99 | 0.456 | 0.19 | 0.20 | 84 | 0.456 |
Abbreviations: MCP: Middle Cerebellar Peduncle; PCT: Pontine Crossing Tract; CC: Corpus Callosum; CST: Corticospinal Tract; ML: Medial Lemniscus; ICP: Inferior Crebellar Peduncle; SCP: Superior Cerebellar Peduncle; CP: Cerebral Peduncle; IC: Internal Capsule; CR: Corona Radiata; PTR: Posterior Thalamic Radiation; SS: Sagittal Stratum; EC: External Capsule; SLF: Superior Longitudinal Fasciculus; SFF: Superior Fronto-occipital Fasciculus; UF: Uncinate Fasciculus.
P values were corrected by means of false discovery rate (FDR).